SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-023120
Filing Date
2017-04-28
Accepted
2017-04-28 14:45:44
Documents
7
Period of Report
2017-06-07
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A v465343_def14a.htm DEF 14A 318745
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_mustangbio.jpg GRAPHIC 62056
4 GRAPHIC sig_robyn.jpg GRAPHIC 9830
5 GRAPHIC spacer.gif GRAPHIC 43
6 GRAPHIC v465343_proxy-1.jpg GRAPHIC 988605
7 GRAPHIC v465343_proxy-2.jpg GRAPHIC 458183
  Complete submission text file 0001144204-17-023120.txt   2411671
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

IRS No.: 473828760 | State of Incorp.: DE | Fiscal Year End: 0312
Type: DEF 14A | Act: 34 | File No.: 000-55668 | Film No.: 17794511
SIC: 2834 Pharmaceutical Preparations